home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Courses and Workshops
Search  -  prev / next

Formulation Design and Troubleshooting of Pharmaceutical Dosage Forms: Tablets

  March 14, 2019  
CfPA-The Center for Professional Advancement, New Brunswick, NJ
October 21-23, 2019

Who Should Attend?
This is an in depth course intended for product development scientists and technologists and support groups concerned with the development, designing and processing of tablets and similar oral products. 

The material will be presented in such a way as to be of value to a varying level of expertise. This course will especially benefit those in:
  • Formulation Development
  • Quality Assurance
  • Research and Development
  • Validation
  • Regulatory Affairs
  • Manufacturing/Production
  • Engineering Support

Note: Persons seeking a broader based program may wish to consider an alternative, more generalized course offered by CfPA in this area of technology.

Course Description
The main aim of this 3-day intensive course is to review the science relating to formulation and process selection in the design of tabletted pharmaceutical products. The course begins with a consideration of the final process of making tablets and meeting the challenges of the API and delivering the targeted therapy. Knowing the targets, the ingredients available and the selection criteria for ingredients are reviewed. The impact of the API, the chosen platform and the strategies for choosing the processes to obtain the targeted performance are reviewed. The program concludes with key aspects of designing principles of setting up DOEs and the role of QbD in creating the operating/design space, investigation and eliminate risk. Evaluation, problem solving and regulatory constraints are discussed at each stage.

Formal sessions of the course are supplemented with informal discussion periods between lecturers and course participants and problem-solving sessions are held on both an open and private basis.
Organized by: CfPA-The Center for Professional Advancement
Invited Speakers:
   Dr. Cecil W. Propst, Managing Director, Propst Consulting Services

Dr. Cecil W. Propst is Managing Director at Propst Consulting Services, a formulation, and engineering support LLC located in Norton Shores MI. He was Director of R&D (Grand Haven site) at SPI Pharma until 2015. He served as Director of Quality Assurance and Technical Services at Fleming and Company, and before that, President of Manufacturing Chemists. His duties included system design, product and process development and regulatory affairs. Previously, he served as cGMP Facilities Director for the University of Maryland at Baltimore, in connection with the University’s SUPAC contract with the FDA. Dr. Propst also served as Director of Technical Development for Stellar Manufacturing; Director of Quality Compliance for SmithKline Beecham; Director, Quality Assurance for Norcliff Thayer (a Revlon Company); and Group Leader/Product Development and Manager/Quality Control for Lewis Howe Company. He serves as a consultant in the area of product development and process investigations for the chemical, diagnostic, food, engineering and beverage industries.


Dr. John K. Tillotson, Technical Manager, Abitec Inc.

Dr. John Tillotson, Technical Manager, Abitec Inc., received his B.S. in Pharmacy from Ferris State University and his Ph.D. in Industrial Pharmacy from the University of Cincinnati.

Dr. Tillotson’s primary areas of interest are quick dissolve tablet technologies, directly compressible modalities and multiple-regression analysis. He was involved with the development and optimization of bumetanide sustained release technologies has several quick dissolve systems for nutraceuticals, OTC, and prescription products. Dr. Tillotson has presented at various workshops, invited symposiums, and/or poster presentations at national and international meetings. His published papers discuss the use of multiple-response optimization and the benefits of various ODT excipient systems. He is a member of the Rho Chi Pharmaceutical Honor Society and of the American Association of Pharmaceutical Scientists. 

Deadline for Abstracts: n/a
Registration: Please click here for registration information.
E-mail: Jmorbit@cfpa.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2019 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.